Pear Therapeutics, Inc. Annual Cost of Revenue in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Pear Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2020 to 2022.
  • Pear Therapeutics, Inc. Cost of Revenue for the quarter ending December 31, 2022 was $1.75M, a 5.89% increase year-over-year.
  • Pear Therapeutics, Inc. Cost of Revenue for the twelve months ending December 31, 2022 was $8.18M, a 56.4% increase year-over-year.
  • Pear Therapeutics, Inc. annual Cost of Revenue for 2022 was $8.18M, a 56.4% increase from 2021.
  • Pear Therapeutics, Inc. annual Cost of Revenue for 2021 was $5.23M, a 205% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $8.18M +$2.95M +56.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $5.23M +$3.52M +205% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $1.72M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.